HOME >> BIOLOGY >> NEWS
NSF funds new Rutgers plant biomaterials initiative

New Brunswick, N.J. The National Science Foundation (NSF) has Rutgers scientists looking to plants as a source of materials for cardiovascular stents, bone and tissue grafts, antiviral and antibacterial food packaging, and personal care products. The research will develop hybrid materials by combining naturally occurring plant substances, such as starch from corn or potatoes, with synthetic degradable polymer biomaterials.

This initiative can yield cost-effective, bio-based materials to replace petroleum-derived plastics while creating new economic opportunities for American farmers now threatened by low commodity prices.

The two-year project is supported by a $600,000 NSF Partnerships for Innovation program grant to the New Jersey Center for Biomaterials (NJCBM) based at Rutgers, The State University of New Jersey. The project will be led by NJCBM Director Joachim Kohn and Assistant Research Professor Carmine Iovine, a new Rutgers faculty member.

This project takes inspiration from George Washington Carver, whose lifework produced products from peanut and soy crops that revolutionized the economy of the South, freeing it from dependence on cotton, Kohn said.

Iovine, recognized for his more than 40 years of industrial experience and expertise in biopolymer and synthetic polymer chemistry, came to Rutgers from New Jersey-based National Starch and Chemical Company, where he served as vice president for research and development of Nationals parent, the ICI Group.

The project team will include Professor Michael Pazzani, vice president for research and graduate and professional education; Assistant Professor Mikhail Chikindas and Research Professor Kit Yam of Rutgers Center for Advanced Food Technology (CAFT) and department of food science; Research Chemist LinShu Liu of the U.S. Department of Agricultures Eastern Regional Research Center; and NJCBM and CAFT industrial members.

Exploring somewhat d
'"/>

Contact: Joseph Blumberg
blumberg@ur.rutgers.edu
732-932-7084 x652
Rutgers, the State University of New Jersey
27-Feb-2007


Page: 1 2

Related biology news :

1. The Cancer Genome Atlas awards funds for technology development
2. NIH funds innovative alzheimers research initiated at UCSB
3. NSF funds biofertilizer research at Rutgers-Camden
4. ResearchChannel awards matching funds for video production
5. Research grant funds studies of climate change and reef ecosystems
6. NHGRI funds large-scale sequencing centers
7. NCI funds Einstein and U. Albany NanoCollege to make worlds smallest cancer detection device
8. Worcester Polytechnic Institute receives $2 million in federal funds for biomedical research centers
9. Columbia University Medical Center receives major new NIH Clinical Science investment funds
10. NIH funds Berkeley Lab research on defense against radiological attack
11. NIH funds 14 High-End Instrumentation grants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NSF funds new Rutgers plant biomaterials initiative

(Date:5/23/2013)... , Automated conserved noncoding sequence (CNS) ... among grasses , Within the genome of each ... undergo little change in position and sequence over millions ... Some of these evolutionarily stable sequences, so-called conserved noncoding ... other genes or the condensation of chromosomes, but the ...
(Date:5/23/2013)... of Public Health at Emory University, along with ... received a $4 million grant over four years ... (Health and Exposome Research Center: Understanding Lifetime Exposures). ... awarded in the United States. , The ... of Environmental Health Sciences (NIEHS) of the National ...
(Date:5/23/2013)... cancer patients unnecessarily undergo surgery or harsh treatments ... slow-growing and aggressive forms of the disease. Researchers ... Medical Institutes are developing technology that allows patients ... relatively mild treatments or take drastic measures. , ... an associate professor of biomedical engineering at Case ...
Breaking Biology News(10 mins):Frontiers news briefs: May 23 2Frontiers news briefs: May 23 3Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Using big data to identify prostate cancers and best treatments 2Using big data to identify prostate cancers and best treatments 3
(Date:5/23/2013)... , May 23, 2013 Venaxis, Inc. ... company focused on obtaining FDA clearance and commercializing its ... announced the pricing of an underwritten public offering of ... to purchase 3,500,000 shares of its common stock at ... combined public offering price of $1.25 per share and ...
(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... MA (PRWEB) May 23, 2013 ... inch wide and provide 15 mm travel range ... The small dimensions make these new positioners ... confined spaces. A vacuum rated version is also ... Drawings, specifications and datasheets can be found at: ...
(Date:5/23/2013)... 2013 BioTrends Research Group, one of ... specialized biopharmaceutical issues, finds that, unaided, one in ... reported that in the past six months, they ... in anticipation of the next generation of HCV ... only 6 percent reported that they had begun ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
Cached News: